AI Article Synopsis

  • There is a need for reliable tools to measure satisfaction with methadone treatment, as current instruments are lacking in this area.
  • This study examined the Spanish version of the Treatment Satisfaction Questionnaire for Medication (TSQM) among 203 methadone-maintained heroin-dependent patients to assess its psychometric properties.
  • Results showed that the TSQM effectively measures satisfaction and displays good internal consistency, suggesting it is a valuable tool for evaluating methadone treatment satisfaction, although further research is necessary to validate these findings.

Article Abstract

There is a manifest lack of psychometrically sound instruments designed for specific and multidimensional assessment of satisfaction with methadone as a medication within the context of methadone maintenance treatment. Therefore, it may be worthwhile to assess the pertinence and utility of using a generic and multidimensional medication satisfaction instrument that has not been specifically developed for use in methadone maintenance treatment.The aim of this study was thus to explore the psychometric properties of the Spanish version of the Treatment Satisfaction Questionnaire for Medication (TSQM version 1.4 [Health Qual Life Outcomes. 2004;2:12]) in a sample of methadone-maintained heroin-dependent patients.Two hundred three methadone-maintained patients filled out the TSQM and other several measures related to the construct of patient satisfaction (eg, Verona Service Satisfaction Scale for methadone treatment). Dimensionality of the TSQM was assessed by means of a confirmatory factor analysis. Internal consistency was examined using the ordinal coefficient α. Spearman correlations were used to explore the relationship between the TSQM and the measures conceptually related to patient satisfaction.Regarding the dimensionality of the TSQM, its original factor structure adequately fitted the data (Satorra-Bentler χ58, 72.14 [P = 0.100]; root-mean-square error of approximation, 0.045; comparative fit index, 0.978). All but 1 of the 4 TSQM subscales showed acceptable to good internal consistency values (0.78-0.89). The dimensions of the TSQM were differentially and congruently correlated with related measures.The results strongly suggest the TSQM value as a brief, generic, and psychometrically sound instrument to assess satisfaction with methadone as a medication in a multidimensional manner. Notwithstanding, more research is needed not only to assess the generalizability of these findings but also to provide pieces of evidence for other psychometric properties, especially the TSQM predictive validity.

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0b013e3182401e09DOI Listing

Publication Analysis

Top Keywords

satisfaction methadone
12
methadone medication
12
psychometric properties
12
tsqm
9
satisfaction
8
properties spanish
8
spanish version
8
version treatment
8
treatment satisfaction
8
satisfaction questionnaire
8

Similar Publications

"I still can feel the sickness": Withdrawal experiences of people on methadone maintenance treatment.

J Subst Use Addict Treat

December 2024

Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY 10003, USA; Center for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY 10003, USA.

Introduction: Opioid withdrawal is a regular occurrence for many people who use illicit opioids (PWUIO) involving acute physical and psychological pain. Yet, there is very little data on the withdrawal experience of people in methadone maintenance treatment (MMT) and almost none from the patients' experience. Learning more about patients' withdrawal experiences can help to inform policies and practices that are better suited to address withdrawal and may improve patient satisfaction as well as uptake and retention.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the quality of life (QoL) perceptions among long-term methadone-dependent patients (MDPs) undergoing methadone maintenance treatment (MMT) for opioid use disorder (OUD).
  • Using qualitative methods, the research involved in-depth interviews with 25 MDPs to explore their experiences and satisfaction in various life aspects post-treatment.
  • Key findings revealed themes of improved physical and mental health, a sense of purpose in life, positive self-perception, enhanced social support, marital satisfaction, and challenges related to fatigue, stigma, and financial strain associated with MMT.
View Article and Find Full Text PDF
Article Synopsis
  • Postoperative pain management is challenging for patients undergoing robot-assisted cystectomy, and researchers studied whether a single dose of intraoperative methadone could help reduce pain and the need for opioids post-surgery.
  • In a clinical trial with 114 patients, those receiving methadone had similar opioid requirements compared to those getting morphine at both 3 and 24 hours after surgery, but pain levels were lower in the morphine group at 48 hours.
  • Patient satisfaction was higher for those given methadone at 24 hours, indicating that while methadone didn't reduce opioid use or pain intensity, it may contribute to greater overall satisfaction.
View Article and Find Full Text PDF
Article Synopsis
  • In Vietnam, public sector clinics currently dominate methadone maintenance treatment (MMT) services for drug users, but private sector involvement is necessary for the future sustainability of these programs due to anticipated declines in foreign aid.
  • A study involving 395 participants from one private and two public clinics assessed patient satisfaction, revealing that while satisfaction was generally high, patients wanted more comprehensive care, particularly in private facilities.
  • The findings suggest that improving administrative procedures and the skill level of health workers in private clinics, as well as integrating MMT with broader healthcare services, is essential for enhancing patient care and program effectiveness.
View Article and Find Full Text PDF

Medication for opioid use disorder (MOUD) is the management of opioid use disorder (OUD) on an outpatient basis with buprenorphine or buprenorphine/naloxone (or methadone, which is limited to federally certified opioid treatment programs). Primary care practices are well poised to provide comprehensive care for patients with OUD, including provision of MOUD. The aim of this study was to assess provider and staff OUD attitudes and role perceptions before and after implementation of a MOUD clinical service line.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!